Silexion Therapeutics director Amnon Peled resigns from board
The company disclosed in a July 31, 2026 filing that Professor Peled stepped down for personal reasons, effective August 1, 2026.
Silexion Therapeutics Corp reported in an 8-K dated July 31, 2026 that Professor Amnon Peled notified the company's board of directors on July 30, 2026 that he was resigning as a board member, citing personal reasons, with the resignation taking effect August 1, 2026.1
The filing addressed the reason for his departure directly. The company stated that the resignation was not connected to any disagreement with the company over its operations, policies, or practices.1
The disclosure was filed under Item 5.02 of Form 8-K, which covers departures and appointments of directors and officers. The filing was signed by Ilan Hadar, identified as Chief Executive Officer of Silexion Therapeutics Corp. No successor to the board seat or further management changes were mentioned in the filing.
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.